National Kapodistrian University of Athens Lab Histology-Embryology, Medical School
University of Dundee Ninewells Hospital and Medical School,
University of Manchester Faculty Institute for Cancer Sciences
Biomedical Research Foundation, Academy of Athens Center of Basic Research
Intelligencia
EMBO member
Academia Europae
European Academy of Cancer Sciences
Research interests
The main research interest of the Molecular Carcinogenesis Group (MCG) is focused on deciphering how cells react to oncogenic stimuli to preserve homeostasis. Within this context it investigates how cell cycle deregulation, genomic instability and senescence fuels cancer progression. Based on the extensive molecular pathology experience that the group possesses, notable clinic-pathological observations are functionally recapitulated in vitro and in vivo, aiming to decode the underlying mechanisms driving aberrant cellular behavior. The major achievements of the group are the following:
1. Establishing the “Oncogene-induced DNA damage model for cancer development”
2. Clarifying the functional interplay of the two major antitumor barriers:
DDR and ARF
3. Revealing the oncogenic role of the replication licensing machinery in cancer
4. Demonstrating that Genomic Instability drives Escape from Senescence fueling Cancer Progression
5. Developing pioneer senescence biomarkers (SenTraGorTM – GLF16)
6. Understanding how cellular senescence is involved in age-related pathologies
7. Exploiting molecular patterns for precision medicine based cancer therapy
8. Contributing to our understanding of the role that inflammation plays in cancer
9. Development of machine learning algorithms to predict biological responses
10. Providing anthropological evidence of humans evolution
1. Establishing the “Oncogene-induced DNA damage model for cancer development”
Key studies from 1996 to 2011 leading and supporting the model:
1. J Pathol 1996
2. Br J Cancer 1998
3. Am J Pathol 1998
4. Cancer 2000
5. Cancer Res 2001
6. J Pathol 2002* (J Pathol 2002)
7. Am J Pathol 2002
8. J Pathol 2004
9. Am J Pathol 2004* (F1000 Prime)
10. Nature 2005* (Nature 2005)
11. Nature 2006* (Nature 2006)
12. J Pathol 2006
13. In t J cancer 2006
14. Cancer Res 2007a
15. Oncogene 2008
16. Am J Pathol 2009
17. Nat Genet 2011* (Nat Genet 2011)
18. Nat Cell Biol 2011* (F1000 Prime)
*Publications with recognitions
This led in ...
… establishing Genomic Instability and Senescence, as hallmarks of cancer
2. Clarifying the functional interplay of the two major antitumor barriers: DDR and ARF
Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
